Calamos Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-642,611
Closed -$10.1M 1330
2022
Q2
$10.1M Sell
642,611
-36,736
-5% -$617K 0.04% 480
2022
Q1
$10.5M Buy
+679,347
New +$8.57M 0.04% 500
2014
Q2
Sell
-13,315
Closed -$422K 657
2014
Q1
$422K Buy
+13,315
New +$370K ﹤0.01% 601

Other funds holding PTEN

Calamos Advisors's PTEN Position: Q3 2022 in Review

Calamos Advisors sold out of Patterson-UTI (PTEN) in Q3 2022, closing a stake of 642,611 shares — an estimated $10.1M sold.

Calamos Advisors first reported a position in PTEN in Q1 2014 and held it in 3 quarters. The position peaked at $10.5M in Q1 2022. 285 funds tracked by Wall St. Rank hold PTEN as of Q3 2022.

  • Calamos Advisors reported no remaining Patterson-UTI position as of Q3 2022 after selling out during the quarter.
  • Calamos Advisors sold 642,611 Patterson-UTI shares in Q3 2022, an estimated $10.1M.
  • Calamos Advisors first reported a position in Patterson-UTI in Q1 2014 and held it in 3 quarters.
  • Calamos Advisors's Patterson-UTI position peaked at $10.5M in Q1 2022.
  • 285 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2022.

Based on Calamos Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.